RE:DEVELOPMENTS Thanks for the post! I agree on the type of approval not stating asymptomatic but I'm more concerned that people think it should say that. I think it's unrealistic to think we'll get a better clearance than Abbott.
I do think that a more sensitive test will be a let differentiator and make Sona's test very in demand. The others don't make any claims about their sensitivity at lower viral loads and there's a reason for that! sales will be through the roof with clearance. They just need to get the contract manufacturers to churn out all they can then! I like the reference to multiple manufacturers in recent interviews because that's realistically required to hit the volumes required to meet this demand.